Cargando…

Pityriasis lichenoides chronica in a patient on tafasitamab and lenalidomide therapy for diffuse large B-cell lymphoma

Detalles Bibliográficos
Autores principales:	Roster, Katie, Kann, Rebecca, Zufall, Alina, Farabi, Banu, Russo, Marian, Shulman, Kenneth, Safai, Bijan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493230/ https://www.ncbi.nlm.nih.gov/pubmed/37701883 http://dx.doi.org/10.1016/j.jdcr.2023.07.038

Ejemplares similares

Dermoscopy of Pityriasis Lichenoides Chronica in an Indian Girl
por: Sonthalia, Sidharth, et al.
Publicado: (2020)

Dermatoscopic rainbow pattern in lichen planus pigmentosus inversus in a middle-aged African American man
por: Roster, Katie, et al.
Publicado: (2023)

Pityriasis Lichenoides Chronica of Esophagus: A Rare Case Report
por: Tahir, Muhammad, et al.
Publicado: (2022)

Pityriasis Lichenoides Chronica Associated with Herpes Simplex Virus Type 2
por: González Rodríguez, Antonio Javier, et al.
Publicado: (2012)

Etanercept-Induced Pityriasis Lichenoides Chronica in a Patient with Rheumatoid Arthritis
por: Echeverri, Andrés F., et al.
Publicado: (2015)

Pityriasis lichenoides chronica induced by COVID-19 messenger RNA vaccination
por: Al Muqrin, Abdullah M., et al.
Publicado: (2022)

Pityriasis lichenoides chronica–like drug eruption developing during pembrolizumab treatment for metastatic melanoma
por: Mutgi, Krishna A.J., et al.
Publicado: (2016)

The Effectiveness of Narrow Band Uvb (Nb-Uvb) In the Treatment of Pityriasis Lichenoides Chronica (PLC) In Vietnam
por: Huu, Doanh Le, et al.
Publicado: (2019)

[Translated article] A Case of Pityriasis Lichenoides Chronica in a Patient With COVID-19 Infection
por: Durusu, I.N., et al.
Publicado: (2022)

Role of streptococcal infection in the etiopathogenesis of pityriasis lichenoides chronica and the therapeutic efficacy of azithromycin: a randomized controlled trial
por: Elbendary, Amira, et al.
Publicado: (2022)

Keratosis lichenoides chronica successfully treated with isotretinoin and methotrexate
por: Li, Alvin W., et al.
Publicado: (2017)

Keratosis Lichenoides Chronica (Nekam’s Disease): Dermoscopic and in Vivo Reflectance Confocal Microscopy Findings
por: Ozturk, Ayris, et al.
Publicado: (2023)

Childhood‐onset keratosis lichenoides chronica: A case report
por: Nasiri, Soheila, et al.
Publicado: (2021)

Erythema Ab Igne with Histological Features of Keratosis Lichenoides Chronica
por: Prohic, Asja, et al.
Publicado: (2021)

Childhood Keratosis Lichenoides Chronica: Treated Successfully with Acitretin and NBUVB
por: Sahu, Priyadarshini, et al.
Publicado: (2022)

A case study on the dermatoscopic findings of Darier's disease in skin type VI
por: Khan, Samavia, et al.
Publicado: (2023)

Keratosis lichenoides chronica: A case report and focused overview of the literature
por: Aromolo, Italo Francesco, et al.
Publicado: (2021)

Clinical Treatment Guidelines for Tafasitamab plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
por: Nedved, Adrienne, et al.
Publicado: (2023)

A case of pediatric keratosis lichenoides chronica with unusual presentation of severe oral erosions
por: Nasimi, Maryam, et al.
Publicado: (2018)

RE-MIND: Comparing Tafasitamab + Lenalidomide (L-MIND) with a Real-world Lenalidomide Monotherapy Cohort in Relapsed or Refractory Diffuse Large B-cell Lymphoma
por: Zinzani, Pier Luigi, et al.
Publicado: (2021)

Transformed Waldenström Macroglobulinemia Responsive to Tafasitamab Plus Lenalidomide: A Case Report
por: Nasir, Syed Alishan, et al.
Publicado: (2022)

Rapid diagnosis and clinical management of kerion in a pediatric patient with reflectance confocal microscopy
por: Khan, Samavia, et al.
Publicado: (2023)

The use of tafasitamab in diffuse large B-cell lymphoma
por: Düll, Johannes, et al.
Publicado: (2021)

The European Medicines Agency Review of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
por: Delgado, Julio, et al.
Publicado: (2021)

Pityriasis lichenoides et varioliformis acuta after influenza vaccine
por: de Castro, Breno Augusto Campos, et al.
Publicado: (2015)

Clinical, Dermatoscopic, and Histological Findings in a Diagnosis of Pityriasis Lichenoides
por: Clarey, Dillon D, et al.
Publicado: (2020)

Pityriasis Lichenoides-Like Mycosis Fungoides: A Case Report
por: Park, Lily, et al.
Publicado: (2023)

A Mild Case of Adult-Onset Keratosis Lichenoides Chronica Successfully Treated with Narrow-Band UVB Monotherapy
por: Nomura, Takashi, et al.
Publicado: (2012)

CD4/CD8 Dual Positive Pityriasis Lichenoides Like Mycosis Fungoides Presenting with Both Pityriasis Lichenoid Lesions and Hypopigmented Patches: A Rare Presentation
por: Rao, Angoori Gnaneshwar, et al.
Publicado: (2022)

Pityriasis Lichenoides et Varioliformis Acuta: Case Report and Review of the Literature
por: Pereira, Neide, et al.
Publicado: (2012)

Pityriasis Lichenoides Following SARS-CoV-2 Infection/Vaccination
por: Feschuk, Aileen M., et al.
Publicado: (2023)

Tafasitamab for the treatment of relapsed or refractory diffuse large B-cell lymphoma
por: Salles, Gilles, et al.
Publicado: (2021)

Conjunctival Inflammatory Nodule in a Patient with Pityriasis Lichenoides et Varioliformis Acuta
por: Moisseiev, Elad, et al.
Publicado: (2010)

Pityriasis lichenoides-like secondary syphilis and neurosyphilis in a HIV-infected patient
por: Pastuszczak, Maciej, et al.
Publicado: (2013)

Pityriasis Lichenoides-like Mycosis Fungoides: Clinical and Histologic Features and Response to Phototherapy
por: Jang, Min Soo, et al.
Publicado: (2016)

Pityriasis lichenoides et varioliformis acuta in skin of color: new observations by dermoscopy
por: Ankad, Balachandra S., et al.
Publicado: (2017)

Pityriasis Lichenoides et Varioliformis Acuta as a Complication of COVID-19 Infection
por: De La Garza, Henriette, et al.
Publicado: (2022)

Pityriasis lichenoides presented with skin rash mimicking Urticaria: A case report
por: Madawi, Dalal, et al.
Publicado: (2023)

Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma
por: Duell, Johannes, et al.
Publicado: (2021)

PB2304: FIVE-YEAR SUBGROUP ANALYSIS OF TAFASITAMAB + LENALIDOMIDE FROM THE PHASE II L-MIND STUDY IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
por: Duell, Johannes, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8633q64crvp465nnjnbpe2j8s8